新型冠状病毒肺炎合并艰难梭菌继发感染的病例报告
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection.
作者信息
Batra Priyam, Khullar Swati, Choudhary Mamta, Saikiran K V P, Kaginalkar Ananya, Singh Sheetal, Mohan Anant, Chaudhry Rama
机构信息
Department of Microbiology, Microbiology Office, Room No. 2054, 2nd Floor, Teaching Block, AIIMS, New Delhi-110029, India.
AIIMS, New Delhi-110029, India.
出版信息
Indian J Med Microbiol. 2023 Sep-Oct;45:100356. doi: 10.1016/j.ijmmb.2023.01.014. Epub 2023 May 23.
Abstract
There has been an overuse of antibiotics in most patients suffering from COVID-19 which predisposes patients to hospital acquired C. difficile Infection (CDI). Also, COVID infection of the gastrointestinal tract also predisposes the patient to CDI. We here present a fatal case of SARS-CoV-2 coinfection with CDI.
摘要
在大多数新冠肺炎患者中，抗生素的使用存在过度现象，这使患者易患医院获得性艰难梭菌感染（CDI）。此外，胃肠道的新冠感染也使患者易患CDI。我们在此报告一例SARS-CoV-2与CDI合并感染的致命病例。
相似文献
1
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection.新型冠状病毒肺炎合并艰难梭菌继发感染的病例报告
Indian J Med Microbiol. 2023 Sep-Oct;45:100356. doi: 10.1016/j.ijmmb.2023.01.014. Epub 2023 May 23.
2
Clostridioides difficile infection (CDI) during the COVID-19 pandemic.艰难梭菌感染（CDI）在 COVID-19 大流行期间。
Anaerobe. 2022 Apr;74:102518. doi: 10.1016/j.anaerobe.2022.102518. Epub 2022 Jan 19.
3
Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.我们对 80 例 SARS-CoV-2-艰难梭菌合并感染的经验：一项观察性研究。
Medicine (Baltimore). 2022 Jul 8;101(27):e29823. doi: 10.1097/MD.0000000000029823.
4
Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.COVID-19 大流行期间艰难梭菌感染复杂病程和复发的危险因素。
Przegl Epidemiol. 2022;77(1):23-33. doi: 10.32394/pe.77.02.
5
COVID-19 and Coinfection Analysis in the Intensive Care Unit.重症监护病房中的新型冠状病毒肺炎及合并感染分析
Antibiotics (Basel). 2024 Apr 17;13(4):367. doi: 10.3390/antibiotics13040367.
6
Outcomes in Patients with SARS-CoV-2 and Coinfection.感染新型冠状病毒2（SARS-CoV-2）及合并感染患者的预后
Infect Drug Resist. 2021 Apr 28;14:1645-1648. doi: 10.2147/IDR.S305349. eCollection 2021.
7
infection epidemiology and clinical characteristics in COVID-19 pandemic.新型冠状病毒肺炎大流行中的感染流行病学及临床特征
Front Med (Lausanne). 2022 Aug 22;9:953724. doi: 10.3389/fmed.2022.953724. eCollection 2022.
8
Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.COVID-19 住院患者中艰难梭菌感染的临床特征、预测因素和结局——来自塞尔维亚伏伊伏丁那大学临床中心 COVID 医院的单中心经验。
Medicina (Kaunas). 2022 Sep 12;58(9):1262. doi: 10.3390/medicina58091262.
9
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
10
Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.儿童相关的艰难梭菌感染：文献复习。
J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S22-S26. doi: 10.1093/jpids/piab064.
本文引用的文献
1
Clostridioides difficile infection (CDI) during the COVID-19 pandemic.艰难梭菌感染（CDI）在 COVID-19 大流行期间。
Anaerobe. 2022 Apr;74:102518. doi: 10.1016/j.anaerobe.2022.102518. Epub 2022 Jan 19.
2
COVID-19 and Fulminant Colitis Co-Infection.新型冠状病毒肺炎与暴发性结肠炎合并感染
Eur J Case Rep Intern Med. 2021 Aug 24;8(8):002771. doi: 10.12890/2021_002771. eCollection 2021.
3
Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.新型冠状病毒肺炎中的微生物共感染：相关共生菌群及发病机制的潜在机制。
Microb Pathog. 2021 Jul;156:104941. doi: 10.1016/j.micpath.2021.104941. Epub 2021 May 4.
4
Outcomes in Patients with SARS-CoV-2 and Coinfection.感染新型冠状病毒2（SARS-CoV-2）及合并感染患者的预后
Infect Drug Resist. 2021 Apr 28;14:1645-1648. doi: 10.2147/IDR.S305349. eCollection 2021.
5
Clostridium Difficile and Noncirrhotic Hyperammonnemia in a Patient With COVID-19 Infection.一名新冠肺炎感染患者的艰难梭菌与非肝硬化性高氨血症
Cureus. 2021 Apr 17;13(4):e14533. doi: 10.7759/cureus.14533.
6
Clostridium Difficile and COVID-19: Novel Risk Factors for Acute Portal Vein Thrombosis.艰难梭菌与2019冠状病毒病：急性门静脉血栓形成的新危险因素
Case Rep Vasc Med. 2021 Feb 27;2021:8832638. doi: 10.1155/2021/8832638. eCollection 2021.
7
COVID-19 and coinfection with Clostridioides (Clostridium) difficile in an infant with gastrointestinal manifestation.一名有胃肠道表现的婴儿感染新冠病毒并合并艰难梭菌感染
Einstein (Sao Paulo). 2020 Dec 7;18:eRC6048. doi: 10.31744/einstein_journal/2020RC6048. eCollection 2020.
8
Severe colitis as potential late complication associated with COVID-19.严重结肠炎作为与COVID-19相关的潜在晚期并发症。
Ann R Coll Surg Engl. 2020 Sep;102(7):e176-e179. doi: 10.1308/rcsann.2020.0166. Epub 2020 Aug 17.
9
Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020年3月至4月，美国密歇根州底特律市新冠病毒疾病患者中的艰难梭菌感染情况
Emerg Infect Dis. 2020 Sep;26(9):2299-300. doi: 10.3201/eid2609.202505. Epub 2020 Jul 3.
10
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
Zotero 插件